Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cancer|June 20, 2020
Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancerGlenn J Hanna, Jeffrey P Guenette, Nicole G Chau, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 12, 2009
Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatinDaniel D Karp, Michael N Pollak, Roger B Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2010
Molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor I receptor inhibitionAntonio Gualberto, Marisa Dolled-Filhart, Mark Gustavson, et al.
The Lancet. Oncology|December 29, 2009
Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort studyDavid Olmos, Sophie Postel-Vinay, L Rhoda Molife, et al.
Journal of Translational Medicine|May 3, 2008
Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanomaBegoña Comin-Anduix, Yohan Lee, Jason Jalil, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2021
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS MutationsAlan L Ho, Irene Brana, Robert Haddad, et al.
Blood Advances|September 30, 2021
Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markersMarta Rodríguez, Ruth Alonso-Alonso, Laura Tomás-Roca, et al.
Leukemia|June 26, 2021
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasmsDavid P Steensma, Martin Wermke, Virginia M Klimek, et al.
Pageof 3